Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.
Colossal Biosciences
9 followers
Discovery Life Sciences
3 followers
Mineralys Therapeutics
3 followers
Immunome
2 followers
Avalyn Pharma
2 followers
Ultima Genomics
6 followers
Celcuity
1 follower
MedRhythms
1 follower
Centessa Pharmaceuticals
3 followers
Artiva Biotherapeutics
2 followers
Elemental Enzymes
1 follower
Glyphic Biotechnologies
1 follower